Remove 2017 Remove Blogging Remove Technical Review
article thumbnail

Cybersecurity Firm Illumio’s Alan Cohen on the Tech Backlash of 2017

Xconomy

One of the largest and most consequential data breaches in 2017 afflicted credit reporting agency Equifax, and it was hardly the only victim. The drumbeat of mishaps and scandals this year also included charges of sexual harassment and gender discrimination among tech companies and investors. Have all these.

article thumbnail

HBCUvc founder Hadiyah Mujhid on one way investors can advance racial equity

TechCrunch LA

Some firms have said that they’re going to turn to HBCUvc , a nonprofit organization that helps students from historically Black colleges and universities enter venture and tech. The program is expanding to Chicago in 2021, the blog post notes. Read the whole HBCUvc blog post here.

Equity 220
Insiders

Sign Up for our Newsletter

This site is protected by reCAPTCHA and the Google Privacy Policy and Terms of Service apply.

Trending Sources

article thumbnail

ServiceTitan is LA’s least likely contender to be the next billion-dollar startup

TechCrunch LA

seems like an unlikely place to grow one of the next billion-dollar startups in the booming Los Angeles tech ecosystem. It was Iconiq that put a whopping $80 million into ServiceTitan just last year — and while the 2017 cash infusion may have been larger, the company’s valuation has continued to rise.

Glendale 271
article thumbnail

Xconomy Special Report: 12 San Diego Tech Startup to Watch in 2017

Xconomy

View the Slideshow A little more than a year ago, amid a resurgence in San Diego’s software sector, Xconomy identified a baker’s dozen of local tech companies to watch in 2016. I met with Seed San Diego partners Taner Halicioglu and Eric Gasser, who also reviewed the companies and provided their feedback. I widened my net this year.

article thumbnail

Bio Roundup: FDA Says No, PCSK9 Value Fight, CRISPR Intrigue & More

Xconomy

The CRISPR news this week doesn’t need a metaphor; the drama that MIT Technology Review reported can stand alone. Everyone is waiting until 2017, when huge studies of the drugs’ ability to prevent heart attacks and strokes start to provide data. Data from the other three trials should come in late 2016 or early 2017.

article thumbnail

Bio Roundup: Theranos Cuts, Alnylam Stops, Nobel Eats Its Own & More

Xconomy

military’s high-tech think tank DARPA described Safe Genes, a new program to fund safety measures that can be built into genome editing technology or counter its potential wayward effects. The funding could be as much as $100 million, and the first grants will be announced in 2017. —The U.S. THE ENVELOPE, PLEASE.

article thumbnail

Bio Roundup: Precision Med and Google, Heron, Lilly, Sarepta & More

Xconomy

government’s Precision Medicine Initiative is an ambitious effort to collect the genomic data of 1 million Americans, and tech giant Alphabet (NASDAQ: GOOG ) is deeply involved. The new company, expected to launch in 2017, will trade on the Nasdaq under the symbol “BIVV” when the split is complete. —The U.S. —David H.

Google 40